Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
This clinical trial update provides expanded access to MDV3100 (enzalutamide) for patients with progressive castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone [Phase 2]
Phase 2 SWITCH study evaluated switching from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients treate…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001 [Phase 2]
Phase 2 extension study report on ODM-201 (darolutamide) in castration-resistant prostate cancer, focusing on safety and tolerability.
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) [Phase 2]
Phase 2 trial evaluating mitoxantrone with or without cetuximab as second-line therapy for castration-resistant prostate cancer; the study c…
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Phase 1/2 study assessing Alpharadin in combination with Docetaxel in patients with bone metastases from castration-resistant prostate cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Second-line Chemotherapy in Castration Resistant Prostate Cancer [Phase 2]
A Phase 2 trial testing second-line chemotherapy for metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 3]
A Phase 3 trial compares cabazitaxel at 20 mg/m² vs 25 mg/m² with prednisone in metastatic castration-resistant prostate cancer; results hav…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
This completed Phase 1 trial evaluated the safety and pharmacokinetics of escalating doses of DSTP3086S in patients with metastatic castrati…
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy [Phase 2]
Phase 2 proof-of-concept study investigating maintenance tasquinimod in metastatic castration-resistant prostate cancer patients non-progres…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases [Phase 1, Phase 2]
This Phase 1/2 trial update assesses the safety of re-treatment with Radium-223 dichloride in men with metastatic castration-resistant prost…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer
Completed clinical trial evaluating feasibility, evaluability, and variability in markers of drug action in metastatic castration-resistant …
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer [Phase 4]
Phase 4 trial completion update for cabazitaxel combined with prednisone and neutropenia-prophylaxis in metastatic castration-resistant pros…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC [Phase 2]
DexTech Medical AB's Phase IIb study of ODX (Osteodex) in metastatic castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer [Phase 4]
This Phase 4 trial update assesses the safety of cabazitaxel (Jevtana) in patients with metastatic castration-resistant prostate cancer. The…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 study evaluating the impact of Orteronel on QT/QTc interval in patients with metastatic castration-resistant prostate cancer; result…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer [NA]
Pilot study results for a combination of parenteral testosterone and oral etoposide in men with castration-resistant prostate cancer; the tr…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone [Phase 2]
A Phase 2 trial of cabozantinib in metastatic castration-resistant prostate cancer with bone metastases was terminated, and results have bee…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer [Phase 2, Phase 3]
The Phase 2/3 clinical trial evaluating F-choline PET for early response assessment in castration-resistant prostate cancer has been termina…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
This document reports the completion of a Phase 2 trial evaluating BIND-014, a docetaxel nanoparticle formulation, in patients with metastat…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer [Phase 2]
This document reports the completion results of an open Phase 2 trial evaluating the efficacy and safety of oral thalidomide in patients wit…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer [Phase 2]
Phase 2 pilot study evaluating an exercise program in patients with metastatic castration-resistant prostate cancer undergoing docetaxel-bas…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) [Phase 2]
Phase 2 clinical trial evaluating the combination of thalidomide and Doxil in patients with androgen-independent prostate cancer; results ha…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program [NA]
A completed clinical trial update evaluating TaRgets in Genito Urinary Screening Program for metastatic castration-resistant prostate cancer…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer [Phase 2]
Phase 2 study of EMD 525797 in asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer has completed and results …